Skip to main content
. Author manuscript; available in PMC: 2021 Nov 3.
Published in final edited form as: Gastroenterology. 2021 Aug 3;161(4):1118–1132. doi: 10.1053/j.gastro.2021.07.042

Table 3:

Musculoskeletal Conditions Associated With Inflammatory Bowel Disease: Therapy of Peripheral and Axial Arthritis in Inflammatory Bowel Disease


Prevalence Diagnosis Therapy
Peripheral arthritis (pSpA) 5–14%i n UC
10–20% in CD
Clinical (and US or MRI) Treatment of intestinal inflammation
COX-2 inhibitors
Corticosteroids (short term)
Sulfasalazine (esp. in UC)
Methotrexate
Anti-TNF
Axial arthritis/Spondyl-arthopathy (axSpA) Up p to 50 %in CD
symptomatic in up to 8%
Clinical and MRI anti-TNF